| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
4 companies
Emster Kurt Von is a Director at PCVX, with reported holdings spanning 4 companies. Recent filings cover 5 purchases and 47 sales. Those positions are worth an estimated $34.6M at current prices.
Our model assigns Emster Kurt Von a middling insider score of 62/100, based on 3 past trades. Over a 12-month horizon, 66.7% of those trades were profitable, with an average 12-month return of -2.5%.
Emster Kurt Von's largest disclosed position is in CRSP as Director, worth about $34.6M. The recent filings there lean toward selling, a net 1,382,466 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 13, 2023 | JSPR Jasper Therapeutics, Inc. | Director | Sell | 9,075 | $1.49 | $13,524.47 | -30.0% | -2.7% | +84.8% | |
| May 18, 2021 | VERA Vera Therapeutics, Inc. | Director | Buy | 790,555 | $11.02 | $8,714,653.25 | +36.4% | +37.7% | +32.9% | |
| Jun 16, 2020 | PCVX Vaxcyte, Inc. | Director | Buy | 12,500 | $16.00 | $200,000.00 | +0.3% | - | - | |
| Dec 18, 2018 | CRSP Crispr Therapeutics AG | Director | Sell | 72,934 | $29.85 | $2,176,898.24 | -5.9% | - | - | |
| Jun 5, 2018 | CRSP Crispr Therapeutics AG | Director | Sell | 920 | $12.51 | $11,509.20 | -4.8% | - | - | |
| May 14, 2018 | CRSP Crispr Therapeutics AG | Director | Sell | 650,000 | $54.39 | $35,352,455.99 | -34.4% | - | - | |
| Jan 5, 2018 | CRSP Crispr Therapeutics AG | Director | Sell | 92,337 | $26.96 | $2,489,405.52 | -4.8% | - | - | |
| Jan 5, 2018 | CRSP Crispr Therapeutics AG | Director | Buy | 65,934 | $22.75 | $1,499,998.50 | +3.6% | - | - | |
| Jan 2, 2018 | CRSP Crispr Therapeutics AG | Director | Sell | 37,754 | $26.76 | $1,010,123.37 | -1.9% | - | - | |
| Aug 28, 2017 | CRSP Crispr Therapeutics AG | Director | Sell | 88,011 | $19.79 | $1,741,737.69 | -4.3% | - | - |